Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon therapy for condylomata acuminata.

L J Eron, F Judson, S Tucker

    The New England Journal of Medicine
    |October 23, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Scintillation light detection in the 6-m drift-length ProtoDUNE Dual Phase liquid argon TPC.

    The European physical journal. C, Particles and fields·2022
    Same author

    Search for an Excess of Electron Neutrino Interactions in MicroBooNE Using Multiple Final-State Topologies.

    Physical review letters·2022
    Same author

    First Measurement of Energy-Dependent Inclusive Muon Neutrino Charged-Current Cross Sections on Argon with the MicroBooNE Detector.

    Physical review letters·2022
    Same author

    Search for Neutrino-Induced Neutral-Current Δ Radiative Decay in MicroBooNE and a First Test of the MiniBooNE Low Energy Excess under a Single-Photon Hypothesis.

    Physical review letters·2022
    Same author

    Prospects for beyond the Standard Model physics searches at the Deep Underground Neutrino Experiment: DUNE Collaboration.

    The European physical journal. C, Particles and fields·2021
    Same author

    Search for a Higgs Portal Scalar Decaying to Electron-Positron Pairs in the MicroBooNE Detector.

    Physical review letters·2021
    Same journal

    Ebola at 50 - Lessons for Outbreak Response and Preparedness.

    The New England journal of medicine·2026
    Same journal

    Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.

    The New England journal of medicine·2026
    Same journal

    Ianalumab plus Eltrombopag in Immune Thrombocytopenia.

    The New England journal of medicine·2026
    Same journal

    Hypertension Control in Low-Income Patients. Reply.

    The New England journal of medicine·2026
    Same journal

    Hypertension Control in Low-Income Patients.

    The New England journal of medicine·2026
    Same journal

    Hypertension Control in Low-Income Patients.

    The New England journal of medicine·2026
    See all related articles

    Interferon alpha-2b injections effectively treated genital warts, significantly reducing wart size and clearance rates compared to placebo. This therapy was well-tolerated, with minimal disruptions from side effects.

    Area of Science:

    • Dermatology
    • Virology
    • Immunology

    Background:

    • Current therapies for condylomata acuminata (genital warts) demonstrate inconsistent efficacy.
    • Genital warts are a common sexually transmitted infection caused by human papillomavirus (HPV).

    Purpose of the Study:

    • To evaluate the efficacy and tolerability of intralesional interferon alpha-2b compared to placebo for treating condylomata acuminata.

    Main Methods:

    • A randomized, double-blind, placebo-controlled trial was conducted.
    • Interferon alpha-2b (1 X 10(6) IU) or placebo was injected directly into warts three times weekly for three weeks.
    • 257 patients were included in the final analysis after exclusions.

    Main Results:

    • Interferon treatment resulted in a significant reduction in mean wart area (62.4% decrease at 1 week, 39.9% decrease at 13 weeks) versus placebo (1.2% increase, 46% increase).

    Related Experiment Videos

  • Complete wart clearance was achieved in 36% of interferon recipients versus 17% of placebo recipients (P < 0.001).
  • Wart progression occurred in 13% of the interferon group compared to 50% in the placebo group (P < 0.001).

    • Conclusions:

    • Direct intralesional injection of interferon alpha-2b is an effective treatment for condylomata acuminata.
    • The therapy demonstrated a favorable tolerability profile with manageable side effects.